桂林旅游 视觉中国 资料图 11月25日，桂林旅游股份有限公司（桂林旅游，000978.SZ）发布公告，拟公开挂牌转让全资子公司桂 林资江丹霞旅游有限责任公司（下称"资江丹霞公司"）100%股权暨债权。 公告显示，资江丹霞公司2024年全年的营业收入约99.77万元，净亏损约2413.19万元，资产总额约 1800.13万元，负债总额约2.51亿元，应收款项总额约698.36万元。今年1-8月，资江丹霞公司的营业收 入约76.04万元；净亏损约422.07万元，资产总额约1554.27万元，负债总额约2.53亿元，应收款项总额约 470.74万元。 桂林旅游表示，资江丹霞公司虽一直采取强化营销、升级设施、开发新产品、控制成本等多项措施，但 仍无法扭转亏损局面。如继续经营，将可能加大亏损。为优化公司资产结构，提高公司资产运营效率， 减少亏损，公司董事会审议通过了关于拟公开挂牌转让资江丹霞公司100%股权暨债权的议案，公司董 事会同意公司在产权交易机构以公开挂牌方式转让持有的资江丹霞公司100%股权暨所持资江丹霞公司 债权。 以中联资产评估集团广西有限公司出具的《桂林旅游股份有限公司拟公开挂牌转让持有桂林资江丹霞 ...

桂林旅游挂牌转让的资江丹霞公司100%股权暨债权不存在抵押、质押或者其他第三人权利；不涉及重 大争议、诉讼或仲裁事项；不存在查封、冻结等司法措施。 北京商报讯（记者 吴其芸）11月25日，桂林旅游发布公告称，桂林旅游董事会议审议通过了关于拟公 开挂牌转让桂林资江丹霞旅游有限责任公司（以下简称"资江丹霞公司"）100%股权暨债权的议案，相 关事宜已获桂林市国资委批准，挂牌价格为3450万元。 公告披露，资江丹霞公司为桂林旅游的全资子公司，注册资本5000万元，主要经营资江天门山景区。受 市场因素及地理位置等因素影响，资江丹霞公司自2008年以来持续亏损，2008年度至2025年1—8月已累 计亏损2.9亿元。截至2025年8月末，资江丹霞公司净资产-2.37亿元，桂林旅游对资江丹霞公司的债权账 面原值2.43亿元，已计提的坏账准备 2.25亿元，账面净值1865.22 万元。 桂林旅游方面表示，本次交易主要是落实桂林旅游整体战略发展规划，有利于引导资源向优势业务集 中，增强公司核心竞争力。同时，不会对公司经营和业务发展产生重大影响，有利于优化公司资产结 构，提高公司资产运营效率，减少亏损，符合公司和全体股东的利 ...

本次交易完成后，将对2025年合并报表减少归属于母公司净利润3,425.05万元，减少归属于母公司的所 有者权益3,425.05万元。本次交易完成后，预计未来会消减该标的方持续亏损对公司的影响。本次交易 完成后，将优化公司医疗服务业务板块的整体资产质量，并提升该业务板块的综合经营效益。 大东方（600327）(600327.SH)发布公告，公司所属控股子公司上海均瑶医疗健康科技有限公司(简称"均 瑶医疗")拟将所持有的金华联济医院有限公司(简称"金华联济")80%的股权及均瑶医疗对金华联济的债 权转让给金华市林天生物科技有限公司(简称"林天生物")。其中：均瑶医疗持有的金华联济80%股权， 拟以1元转让给受让方;均瑶医疗享有的对金华联济的债权合计约8999.10万元，拟以580万元转让给受让 方。 ...

智通财经APP讯，大东方(600327.SH)发布公告，公司所属控股子公司上海均瑶医疗健康科技有限公司 (简称"均瑶医疗")拟将所持有的金华联济医院有限公司(简称"金华联济")80%的股权及均瑶医疗对金华联 济的债权转让给金华市林天生物科技有限公司(简称"林天生物")。其中：均瑶医疗持有的金华联济80% 股权，拟以1元转让给受让方;均瑶医疗享有的对金华联济的债权合计约8999.10万元，拟以580万元转让 给受让方。 本次交易完成后，将对2025年合并报表减少归属于母公司净利润3,425.05万元，减少归属于母公司的所 有者权益3,425.05万元。本次交易完成后，预计未来会消减该标的方持续亏损对公司的影响。本次交易 完成后，将优化公司医疗服务业务板块的整体资产质量，并提升该业务板块的综合经营效益。 ...

江西长运（600561）(600561.SH)发布公告，为进一步推进资源的优化配置，提升资产运营效率，公司 全资子公司江西抚州长运有限公司拟在产权交易所公开挂牌转让持有的南丰西站土地使用权及地上建筑 物等资产，并拟按照上述资产的评估价值，以778.70万元作为首次挂牌转让底价，最终转让价格以产权 交易所挂牌成交结果为准。 ...

Group 1 - The company announced that it will provide a guarantee for its subsidiary, Huangshan Company, which is seeking a loan of up to 1.7 billion yuan from a banking syndicate for a commercial project in Huangshan District [1][2][3] - The loan will have a term of 5 years and will be secured by land use rights and ongoing construction projects in the specified area [2][3] - The company's board of directors approved the guarantee during meetings held on June 5 and June 26, 2025, and the total guarantee amount authorized for Huangshan Company is expected to be no more than 2 billion yuan [1][2] Group 2 - Huangshan Company is responsible for the development of a commercial project in the Tanjiqiao Town of Huangshan District, and the guarantee is deemed necessary to meet its operational funding needs [4] - Despite Huangshan Company's asset-liability ratio exceeding 70%, it is considered to have stable operations and good creditworthiness, which minimizes the guarantee risk for the company [4] - The company has a total external guarantee amount of 6.978 billion yuan, which accounts for 31.37% of its latest audited net assets, with guarantees to subsidiaries totaling 5.838 billion yuan, or 26.24% of net assets [6]

上海机场（600009）(600009.SH)公告，公司与上海机场(集团)有限公司签订《浦东机场三期扩建捷运资 产转让合同》，向其转让浦东机场三期扩建捷运系统工程部分资产，其账面净值为1.57亿元，转让金额 合计为1.61亿元(不含税)。本次关联交易根据浦东机场四期扩建工程建设需要，为完善浦东机场旅客捷 运系统，增强机场集疏运能力。 ...

Core Viewpoint - Yonghe Intelligent Control has initiated a series of asset sales following the abrupt termination of its control change plan, raising significant market attention [1][4]. Group 1: Asset Sale Details - Yonghe Intelligent Control plans to publicly transfer 100% equity of its wholly-owned subsidiary, Kunming Medical Oncology Hospital, with a minimum listing price of 35.93 million CNY [1]. - This marks the fourth time Yonghe Intelligent Control has publicly listed its oncology hospital assets for sale in the past 12 months, including the transfer of stakes in various other hospitals [2]. - The assessed net assets of Kunming Medical as of July 31, 2025, are 32.45 million CNY, with an appraisal value of 35.93 million CNY, reflecting an increase of 3.47 million CNY and a growth rate of 10.70% [1][2]. Group 2: Financial Performance - For the first seven months of 2025, Kunming Medical reported revenue of 11.58 million CNY and a net loss of 6.59 million CNY, continuing a trend of losses from 2024 [2][3]. - Yonghe Intelligent Control's revenue for the first three quarters of 2025 was 582 million CNY, a year-on-year decline of 7.25%, with a net loss attributable to shareholders of 60.46 million CNY [5]. Group 3: Control Change Attempt - The control change plan involving the transfer of 8% of the company's shares for 320 million CNY was terminated due to the buyer's failure to pay the initial installment [3]. - This was the third failed attempt by the current controlling shareholder to change ownership since taking control in 2019 [3].

Core Viewpoint - The company plans to transfer 100% equity of its wholly-owned subsidiary, Songyang New Materials, through a public listing at the Guangdong Equity Exchange Center, with a starting price of 100 million yuan [1] Group 1: Company Actions - The decision to transfer the subsidiary is aimed at revitalizing existing assets and optimizing the company's structure [1] - The board of directors has approved the transaction, which still requires approval from the shareholders' meeting [1] - The final outcome of the transaction remains uncertain as it does not constitute a major asset restructuring [1] Group 2: Financial Assessment - As of June 30, 2025, the total equity value assessment of Songyang New Materials is approximately 92.5647 million yuan [1] - The subsidiary has been continuously incurring losses due to market downturns and intensified competition, leading to the decision to cease production [1]

Core Viewpoint - Shaanxi Black Cat (601015.SH) is adjusting its coal sector regional layout and promoting the development of its main business by transferring 100% equity of Hongneng Coal Industry and Hongneng Changsheng, along with its debt claims against Hongneng Coal Industry to a buyer [1] Group 1 - The total transaction price is calculated as the tentative transaction price minus asset transfer deductions, plus transitional profit and loss adjustments, and other adjustments [1] - The tentative transaction price is set at 1,576.71 million yuan, which includes an equity transfer price of 439.86 million yuan (tentative) and a debt transfer price of 1,136.85 million yuan [1]